Background and objectives: Sleep disorders (SD) and stroke have long been health concerns. Sleep disorders are known to be a risk factor for stroke, and in recent years it has also been shown that the prevalence of sleep disorders is increased in stroke patients. We inferred that there is some inevitable connection between the two. This study aims to identify common molecular biomarkers and pathways connecting SD and stroke by integrating bioinformatics and machine learning approaches. Methods: We analyzed transcriptome data from the GEO dataset to identify differentially expressed genes (DEGs). Key biological processes, as well as metabolic pathways, were highlighted by GO and KGEE enrichment analyses. Co-expression modules were then identified in the SD and stroke datasets by weighted gene co-expression network analysis (WGCNA), respectively, and machine learning algorithms (RandomForest, LASSO, and XGBoost) were performed to identify ARL2 as a key diagnostic biomarker with high predictive value (AUC = 0.91). This was finally complemented by animal experiments to verify that ARL2 was upregulated in the experimental group. Results: In GO and KEGG enrichment analyses, key biological processes such as ‘response to external stimuli’ and ‘organic metabolic processes’ as well as metabolic pathways such as ‘propionate metabolism’ and ‘oxidative phosphorylation’ were significantly enriched, suggesting their potential roles in the pathogenesis of the two disorders. With WGCNA and machine-learning algorithms analyses, we found that ARL2 is an important common marker for both diseases. Discussion: This study provides insights into the common molecular mechanisms of SD and stroke, highlighting the potential of ARL2 as a diagnostic marker and therapeutic target. Unlike previous studies, we used circulating markers rather than tissue markers, improving the clinical translation in terms of non-invasive, rapid identification of patients at risk for sleep disorders. We need to further investigate the functional role of these genes and their potential in developing targeted therapies for SD and stroke patients.
Background and Purpose: We investigated the risk factors for death in patients with medullary infarction (MI) during a long-term follow-up.Methods: We retrospectively examined 179 consecutive patients (130 men and 49 women) who had clinical and MRI findings consistent with MI between February 2012 and January 2017 at three university hospitals. Long-term outcomes were assessed by telephonic interview. The clinical and radiological features and risk factors for poor outcomes (modified Rankin scale score ≥ 3, all-cause death) were analyzed.Results: Mean age of patients was 58.3 ± 12.8 years (range, 25–87); mean follow-up period after stroke onset was 42.7 ± 13.2 months (range, 24–78). Basilar artery (BA) stenosis >50% was more closely related to medial medullary infarction (MMI) than other types. There was greater frequency of ipsilateral vertebral artery hypoplasia (VAH) or V4AH and V4 occlusion in lateral MI than in other types. On rostro-caudal classification, middle (M)+dorsal (D) was most frequent, followed by the ventral (V)+M+D types. 21.2% patients showed poor long-term prognosis. Age ≥ 65 years, recurrent stroke, dysphagia, >50% BA stenosis, and ventral MI were risk factors for poor long-term prognosis. All-cause mortality rate was 10.6%; age ≥ 65 years, recurrent stroke, and dysphagia were risk factors for death in the long-term. Ventral MI and MMI+cerebellar infarction, as well as stroke mechanism of artery-to-artery embolism, were potential risk factors for death in the long-term. Pneumonia and recurrent stroke were major causes of death.Conclusions: Long-term poor outcomes of MI and all-cause mortality were not infrequent. Older age, recurrent stroke, and dysphagia were common risk factors for poor prognosis and death.